AXIL
Axil Brands, Inc.
AXIL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CELH
Celsius Holdings, Inc.
CELH has the edge over AXIL overall, supported by lower modeled downside and stronger fundamentals.
AXIL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
AXIL's revenue, profitability, cash flow and balance sheet are all currently healthy.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AXIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 15x | $5.13 | — |
| Cheap | 20x | $6.66 | +30% |
| Fair | 46x | $15.75 | +207% |
| Expensive | 58x | $19.86 | +287% |
Historical ranges are pointers, not guarantees.
AXIL has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
AXIL Forward outlook
There aren't enough analyst estimates for AXIL to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
AXIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | +113% |
| Q2 2026 | $0.33 | +230% |
| Q1 2022 | -$0.25 | -$0.25 |
| Q4 2021 | -$0.20 | -$0.20 |
| Q3 2021 | -$0.20 | -$0.20 |
| Q2 2021 | -$0.20 | -$0.20 |
| Q1 2021 | $0.00 | $0.00 |
| Q4 2020 | $0.00 | $0.00 |
AXIL's earnings per share have climbed steadily: $0.34 over the past year, up 113% from the year before, and higher year over year for 10 quarters in a row.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
AXIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1M | -11% |
| Q2 2026 | $8.6M | +49% |
| Q1 2026 | $7.3M | +5.4% |
| Q4 2025 | $8.1M | +5.2% |
| Q3 2025 | $6.9M | +17% |
| Q2 2025 | $5.8M | -12% |
| Q1 2025 | $6.9M | +7% |
| Q4 2024 | $7.7M | -8.2% |
AXIL's revenue has picked up after two years of holding roughly level: $6M last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +1.2 points |
| Q2 2026 | 17% | +16 points |
| Q1 2026 | 2.9% | -5.5 points |
| Q4 2025 | 11% | +2.4 points |
| Q3 2025 | 6% | +8.4 points |
| Q2 2025 | 0.8% | -1.8 points |
| Q1 2025 | 8.4% | +10 points |
| Q4 2024 | 8.7% | -6.3 points |
AXIL's operating margin was 7.2% last quarter, up 1.2 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over AXIL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over AXIL on profitability, with a higher operating margin.
AXIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7M | +$4.5M |
| Q2 2026 | -$800.6K | -693% |
| Q1 2026 | $552.8K | +$870.9K |
| Q4 2025 | $906.4K | -3.7% |
| Q2 2025 | $135K | +$529.9K |
| Q1 2025 | -$318.1K | +$604K |
| Q4 2024 | $941.1K | +13% |
| Q2 2024 | -$394.9K | -166% |
AXIL generated $4M in free cash flow over the past year, more than ten times what it generated the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over AXIL on cash flow, with more consistent year-over-year improvement.
AXIL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -4K shares |
| 1 year | +0.1% | +9.1K shares |
| 3 years | -54% | -9.6M shares |
| 5 years | +297% | +6.2M shares |
| Available history | +300% | +6.2M shares |
AXIL has 8M diluted shares, about the same as a year ago.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over AXIL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
AXIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.4x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -3.5x | Net Cash |
| Q1 2025 | -3.2x | Net Cash |
| Q4 2024 | -7.0x | Net Cash |
| Q3 2024 | -3.1x | Net Cash |
AXIL has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
AXIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 10.2 | Oversold |
AXIL's weekly RSI is 36 (neutral) and its Stochastic is 10 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
AXIL PE vs Consumer Defensive Sector
| Metric | AXIL | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 19x | 23% below |
| PE % | 0 | 23 | 23 pts below |
AXIL has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
AXIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.64 | 9% below |
| 20 week MA | $5.92 | 13% below |
| 50 week MA | $6.43 | 20% below |
| 100 week MA | $6.27 | 18% below |
CELH has stronger trend alignment. AXIL is above 0 of 4 weekly averages versus CELH above 2 of 5.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
AXIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.5 | $3.97 | -71% |
| 2025 | $3.97 | $7.41 | +87% |
| 2026 YTD | $7.41 | $5.13 | -31% |
AXIL has finished lower in one of the last two years. It's down 31% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over AXIL on returns for 2026, with the stronger performance.